Cloning of the DNA Vaccine Candidate LACK Gene of Leishmania infantum
Author(s) -
Serkan Karaca,
Şirin Sahra Ceylan,
Süleyman Yazar,
Salih Kuk
Publication year - 2016
Publication title -
turkish journal of parasitology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.207
H-Index - 18
eISSN - 2146-3077
pISSN - 1300-6320
DOI - 10.5152/tpd.2016.3743
Subject(s) - leishmania infantum , plasmid , biology , recombinant dna , dna vaccination , genomic dna , leishmania , virology , gene , cloning (programming) , molecular cloning , dna sequencing , visceral leishmaniasis , leishmaniasis , microbiology and biotechnology , genetics , peptide sequence , parasite hosting , world wide web , computer science , programming language
Leishmaniasis is caused by an obligate intracellular protozoa belonging to Leishmania genus and listed among major tropical diseases by WHO. Because of the high costs, toxicity, and adverse effects of routinely used compounds in the treatment, alternative treatment and vaccine studies are underway. An effective vaccine has not been developed to date. In this study, we aimed to clone one of the most promising DNA vaccine candidates: the homolog-activated C kinase (LACK) gene of Leishmania infantum.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom